<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font32">vaccine </span>
   <span class="font22">SARS-CoV- </span>
   <span class="font20">{border-style </span>
   <span class="font19">etÂ </span>
   <span class="font19">protein </span>
   <span class="font19">px;} </span>
   <span class="font19">virus </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">viral </span>
   <span class="font18">coronavirus </span>
   <span class="font18">disease </span>
   <span class="font17">infection </span>
   <span class="font17">respiratory </span>
   <span class="font17">studies </span>
   <span class="font17">human </span>
   <span class="font16">SARS-CoV </span>
   <span class="font16">immune </span>
   <span class="font15">MERS-CoV </span>
   <span class="font15">clinical </span>
   <span class="font15">development </span>
   <span class="font15">antibodies </span>
   <span class="font15">coronaviruses </span>
   <span class="font15">response </span>
   <span class="font14">protective </span>
   <span class="font14">proteins </span>
   <span class="font14">cell </span>
   <span class="font14">including </span>
   <span class="font14">px; </span>
   <span class="font14">{font-family </span>
   <span class="font13">Vaccine </span>
   <span class="font13">enhancement </span>
   <span class="font13">font-size </span>
   <span class="font13">inÂ </span>
   <span class="font13">multiple </span>
   <span class="font13">pandemic </span>
   <span class="font13">phase </span>
   <span class="font13">rapid </span>
   <span class="font13">responses </span>
   <span class="font13">subjects) </span>
   <span class="font13">(e.g., </span>
   <span class="font13">ADE </span>
   <span class="font13">COVID- </span>
   <span class="font13">DNA </span>
   <span class="font13">NCT </span>
   <span class="font13">Phase </span>
   <span class="font13">double; </span>
   <span class="font13">highly </span>
   <span class="font13">important </span>
   <span class="font13">mRNA- </span>
   <span class="font13">membrane </span>
   <span class="font13">neutralizing </span>
   <span class="font13">research </span>
   <span class="font13">severe </span>
   <span class="font13">spread </span>
   <span class="font13">structural </span>
   <span class="font13">syndrome </span>
   <span class="font13">trials </span>
   <span class="font13">vaccines </span>
   <span class="font13">viruses </span>
   <span class="font12">BCG </span>
   <span class="font12">Elsevier </span>
   <span class="font12">acute </span>
   <span class="font12">antigen </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">candidate </span>
   <span class="font12">emergence </span>
   <span class="font12">fusion </span>
   <span class="font12">infections </span>
   <span class="font12">mice </span>
   <span class="font12">models </span>
   <span class="font12">pathogenesis </span>
   <span class="font12">prefusion </span>
   <span class="font12">related </span>
   <span class="font12">shown </span>
   <span class="font12">solid; </span>
   <span class="font12">spike </span>
   <span class="font12">structure </span>
   <span class="font12">study </span>
   <span class="font12">using </span>
   <span class="font12">virion </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">Development </span>
   <span class="font12">Immune </span>
   <span class="font12">Microbiol. </span>
   <span class="font12">[], </span>
   <span class="font12">activity </span>
   <span class="font12">animal </span>
   <span class="font12">bold </span>
   <span class="font12">candidates </span>
   <span class="font12">cells </span>
   <span class="font12">cellular </span>
   <span class="font12">centre </span>
   <span class="font12">challenge </span>
   <span class="font12">challenges </span>
   <span class="font12">courier; </span>
   <span class="font12">design </span>
   <span class="font12">em; </span>
   <span class="font12">emerging </span>
   <span class="font12">entry </span>
   <span class="font12">evaluated </span>
   <span class="font12">global </span>
   <span class="font12">humans </span>
   <span class="font12">identified </span>
   <span class="font12">individuals, </span>
   <span class="font12">infectious </span>
   <span class="font12">observed </span>
   <span class="font12">pathogenic </span>
   <span class="font12">preclinical </span>
   <span class="font12">protection </span>
   <span class="font12">pt;} </span>
   <span class="font12">resource </span>
   <span class="font12">response. </span>
   <span class="font12">second </span>
   <span class="font12">small </span>
   <span class="font12">vaccine. </span>
   <span class="font12">vitro </span>
  </p>
 </body>
</html>
